Post-ischemic brain damage: Targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment

FEBS Journal

Volumn 276, Issue 1, 2009, Pages 36-45

  Moroni, Flavio ^a,b   Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dipartimento di Farmacologia Preclinica e Clinica   (Italy)

Author keywords

Blood brain barrier; Endothelium; Inflammation; Ischemia; Microglia; Neuroprotection; Neurovascular unit; PARP 1; Pericytes; Stroke

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; INFLAMMATION; NERVE DEGENERATION; NEUROPROTECTION; PRIORITY JOURNAL; SHORT SURVEY; STROKE;

EID: 57649170809     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06768.x     Document Type: Review

References (84)

1. Lo EH, Dalkara T Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4, 399 415.
2. Dirnagl U, Iadecola C Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391 397.
3. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59, 467 477.
4. Savitz SI Fisher M (2007) Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol 61, 396 402.
5. Benveniste H, Drejer J, Schousboe A Diemer N (1984) Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43, 1369 1374.
6. Lombardi G Moroni F (1992) GM1 ganglioside reduces ischemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus. Neurosci Lett 134, 171 174.
7. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23, 1261 1276.
8. Lipton SA Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med 330, 613 622.
9. Meldrum B Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11, 379 387.
10. Nicoletti F, Bruno VM, Copani A, Casabona G Knopfel T (1996) Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 19, 267 271.
11. Moroni F, Lombardi G, Thomsen C, Leonardi P, Attucci S, Peruginelli F, Albani Torregrossa S, Pellegrini-Giampietro DE, Luneia R Pellicciari R (1997) Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid (AIDA), a potent mGluR1 antagonist. J Pharmacol Exp Ther 281, 721 729.
12. Pellegrini-Giampietro DE, Peruginelli F, Meli E, Cozzi A, Albani Torregrossa S, Pellicciari R Moroni F (1999) Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time course and mechanisms. Neuropharmacology 38, 1607 1621.
13. Moroni F, Attucci S, Cozzi A, Meli E, Picca R, Scheideler MA, Pellicciari R, Noe C, Sarichelou I Pellegrini-Giampietro DE (2002) The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology 42, 741 751.
14. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG et al. (2006) NXY-059 for acute ischemic stroke. N Engl J Med 354, 588 600.
15. Garber K (2007) Stroke treatment - light at the end of the tunnel? Nat Biotechnol 25, 838 840.
16. Barone FC Feuerstain GZ (1999) Inflammatory mediators and stroke: novel opportunities for novel therapeutics. J Cereb Blood Flow Metab 19, 819 834.
17. Iadecola C Alexander M (2001) Cerebral ischemia and inflammation. Curr Opin Neurol 14, 89 94.
18. Wang X Feuerstein GZ (2004) The Janus face of inflammation in ischemic brain injury. Acta Neurochir Suppl 89, 49 54.
19. Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, Finklestein SP, Pangalos MN, Poole M, Stiles GL et al. (2008) Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab 28, 217 219.
20. Astrup J, Siesjö BK Symon L (1981) Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 12, 723 725.
21. Iadecola C, Goldman SS, Harder DR, Heistad DD, Katusic ZS, Moskowitz MA, Simard JM, Sloan MA, Traystman RJ Velletri PA (2006) Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease. Stroke 37, 1578 1581.
22. del Zoppo GJ Mabuchi T (2003) Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23, 879 894.
23. Hassa PO, Haenni SS, Elser M Hottiger MO (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70, 789 829.
24. Chambon P, Weill JD Mandel P (1963) Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun 11, 39 43.
25. Cosi C, Suzuki H, Milani D, Facci L, Menegazzi M, Vantini G, Kanai Y Skaper SD (1994) Poly(ADP-ribose)polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 39, 38 46.
26. Zhang J, Dawson VL, Dawson T Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263, 687 689.
27. Szabo C Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia- reperfusion. Trends Pharmacol Sci 19, 287 298.
28. Homburg S, Visochek L, Moran N, Dantzer F, Priel E, Asculai E, Schwartz D, Rotter V, dekel N Cohen-Armon M (2000) A fast signal induced activation of poly(ADP-ribose)polymerase: a downstream target of phospholipase C. J Cell Biol 150, 293 307.
29. Szabo C, Pacher P Swanson RA (2006) Novel modulators of poly(ADP-ribose) polymerase. Trends Pharmacol Sci 27, 626 630.
30. Alano CC Swanson RA (2006) Players in the PARP-1 cell-death pathway: JNK1 joins the cast. Trends Biochem Sci 31, 309 311.
31. Chiarugi A (2005) Poly(ADP-ribosyl)ation and stroke. Pharmacol Res 52, 15 24.
32. Chiarugi A (2005) Intrinsic mechanisms of poly(ADP-ribose) neurotoxicity: three hypotheses. Neurotoxicology 26, 847 855.
33. Gursoy-Ozdemir Y, Can A Dalkara T (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35, 1449 1453.
34. Abdallah Y, Gligorievski D, Kasseckert SA, Dieterich L, Schafer M, Kuhlmann CR, Noll T, Sauer H, Piper HM Schafer C (2007) The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia. Cardiovasc Res 73, 568 574.
35. Zhang Y, Zhang X, Park TS Gidday JM (2005) Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation. J Cereb Blood Flow Metab 25, 868 877.
36. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM Dawson VL (2006) Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci U S A 103, 18314 18319.
37. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J Susin SA (2007) Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 27, 4844 4862.
38. Zhang Y, Park TS Gidday JM (2007) Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol Heart Circ Physiol 292, H2573 H2581.
39. Rosell A Lo EH (2008) Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 8, 82 89.
40. Koh SH, Chang DI, Kim HT, Kim J, Kim MH, Kim KS, Bae I, Kim H, Kim DW Kim SH (2005) Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. Toxicology 214, 131 139.
41. Lenzser G, Kis B, Snipes JA, Gaspar T, Sandor P, Komjati K, Szabo C Busija DW (2007) Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J Cereb Blood Flow Metab 27, 1318 1326.
42. Pacher P, Liaudet L, Oriano FG, Abley JG, Czabo E Czabo C (2002) The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51, 514 521.
43. Carrillo A, Monreal Y, Ramirez P, Marin L, Parrilla P, Oliver FJ Yelamos J (2004) Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleic Acids Res 32, 757 766.
44. Jorgensen MB, Finsen BR, Jensen MB, Castellano B, Diemer NH Zimmer J (1993) Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp Neurol 120, 70 88.
45. del Zoppo GJ (2006) Stroke and neurovascular protection. N Engl J Med 354, 553 555.
46. Chiarugi A (2002) PARP-1: killer or conspirator? The suicide hypothesis revisited. Trends Pharmacol Sci 23, 122 129.
47. Scott GS, Hake P, Kean RB, Virag L, Szabo C Hooper DC (2001) Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J Neuroimm 117, 78 86.
48. Chiarugi A (2002) Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 137, 761 770.
49. Ha HC, Hester LD Snyder SH (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A 99, 3270 3275.
50. Ha HC, Hester LD Snyder SH (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A 99, 3270 3275.
51. Chiarugi A Moskowitz MA (2003) Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 85, 306 317.
52. Koh SH, Park Y, Song CW, Kim JG, Kim K, Kim J, Kim MH, Lee SR, Kim DW, Yu HJ et al. (2004) The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur J Neurosci 20, 1461 1472.
53. Nakajima H, Nagaso H, Kakui N, Ishikawa M, Hiranuma T Hoshiko S (2004) Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells. J Biol Chem 279, 42774 42786.
54. Haddad M, Rhinn H, Bloquel C, Coqueran B, Szabo C, Plotkine M, Scherman D Margaill I (2006) Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol 149, 23 30.
55. Lee JH, Park SY, Shin HK, Kim CD, Lee WS Hong KW (2007) Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat. Brain Res 1152, 182 190.
56. Ullrich O, Diestel A, Eyupoglu IY Nitsch R (2001) Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat Cell Biol 3, 1035 1042.
57. Kraus WL (2008) Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol 20, 294 302.
58. Ducrocq S, Benjelloun N, Plotkine M, Ben-Ari Y Charriaut-Marlangue C (2000) Poly(ADP-ribose) Synthethase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 74, 2504 2511.
59. Strosznajder RP, Jesko H Zambrzycka A (2005) Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury. Mol Neurobiol 31, 149 167.
60. Hamby AM, Suh SW, Kauppinen TM Swanson RA (2007) Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 38, 632 636.
61. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95, 15769 15774.
62. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M Sadeh M (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69, 1404 1410.
63. Alano CC, Kauppinen TM, Valls AV Swanson RA (2006) Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A 103, 9685 9690.
64. Meli E, Baronti R, Pangallo M, Picca R, Moroni F Pellegrini-Giampietro DE (2005) Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures. Neuropharmacology 49 (Suppl 1 80 88.
65. Pieper A, Verma A, Zhang J Snyder SH (1999) Poly(ADP-ribose)polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20, 171 181.
66. Reynolds IJ Hastings TG (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 15, 3318 3327.
67. Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A, Poirier GG, Wang ZQ, Dawson TM Dawson VL (2000) NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci 20, 8005 8011.
68. Duan Y, Gross RA Sheu SS (2007) Ca2 + -dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity. J Physiol 585, 741 758.
69. Giovannelli L, Cozzi A, Guarnieri I, Dolara P Moroni F (2002) Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors. J Cereb Blood Flow Metab 22, 697 704.
70. Ying W, Alano CC, Garnier P Swanson RA (2005) NAD+ as a metabolic link between DNA damage and cell death. J Neurosci Res 79, 216 223.
71. Ying W, Chen Y, Alano CC Swanson RA (2002) Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes. J Cereb Blood Flow Metab 22, 774 779.
72. Endres M, Wang ZQ, Namura S, Waeber C Moskowitz MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17, 1143 1151.
73. Goto S, Xue R, Sugo N, Sawada M, Blizzard KK, Poitras MF, Johns DC, Dawson TM, Dawson VL, Crain BJ et al. (2002) Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 33, 1101 1106.
74. Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M, Klaus JA, Otsuka T, Zhang Z, Koehler RC et al. (2006) Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci U S A 103, 18308 18313.
75. Koh DW, Dawson VL Dawson TM (2005) The road to survival goes through PARG. Cell Cycle 4, 397 399.
76. Cozzi A, Cipriani G, Fossati S, Faraco G, Formentini L, Min W, Cortes U, Wang ZQ, Moroni F Chiarugi A (2006) Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly (ADP-ribose) glycohydrolase null mice. J Cereb Blood Flow Metab 26, 684 695.
77. Culmsee C, Zhu C, Landshamer S, Becattini B, Wagner E, Pellechia M, Blomgren K Plesnila N (2005) Apoptosis-inducing factor triggered by poly(ADP-Ribose) polymerase and bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 25, 10262 10272.
78. Fonfria E, Marshall IC, Benham CD, Boyfield I, Brown JD, Hill K, Hughes JP, Skaper SD McNulty S (2004) TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br J Pharmacol 143, 186 192.
79. McNulty S Fonfria E (2005) The role of TRPM channels in cell death. Pflugers Arch 451, 235 242.
80. Kim JB, Sig CJ, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS Lee JK (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26, 6413 6421.
81. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F Chiarugi A (2007) High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 103, 590 603.
82. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S Moskowitz MA (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28, 927 938.
83. Ditsworth D, Zong WX Thompson CB (2007) Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus. J Biol Chem 282, 17845 17854.
84. Pellicciari R, Camaioni E, Costantino G, Formentini L, Sabbatini P, Venturoni F, Eren G, Bellocchi D, Chiarugi A Moroni F (2008) On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. ChemMedChem 3, 914 923.